insights_auto
Why is NOVOBN up 4,29%?
Dive Deeperchevron_right
NOVOBN:BMV
Novo Nordisk A/S
MXN 741,49
arrow_upward
+4,29%(+30,49) 1D
15 Okt., 07:48:59 GMT-6 · MXN
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NOVOBN...
Open
MXN 728,00
High
MXN 741,49
Low
MXN 728,00
Mkt. cap
134,65 mjd
Avg. vol.
386,00
Volume
12,00
52-wk high
MXN 1 149,99
52-wk low
MXN 630,00
No. of employees
67 k
Open
MXN 728,00
High
MXN 741,49
Low
MXN 728,00
Mkt. cap
134,65 mjd
Avg. vol.
386,00
Volume
12,00
52-wk high
MXN 1 149,99
52-wk low
MXN 630,00
No. of employees
67 k
News stories
From web sources and news partners
Traders Union
·
6 uur gelede
Novo Nordisk stock consolidates amid seller pressure near $38.39 resistance
Yahoo Finance
·
17 uur gelede
Novo Nordisk (NVO) Could Be 63% Undervalued Following Its Share Buyback
The Motley Fool
·
1 dag gelede
AbbVie vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026?
Yahoo Finance
·
1 dag gelede
Why Novo Nordisk (NVO) Dipped More Than Broader Market Today
Profile
Novo Nordisk A/S, doing business as Novo, is a Danish multinational pharmaceutical company. Novo manufactures and markets pharmaceutical products and services, primarily diabetes and obesity medications and devices. The corporation was created in 1989, through a merger of two Danish pharmaceutical companies, which date back to the 1920s.
Novo employs approximately 68,800 people in 80 countries, and markets its products in approximately 170 countries. Novo is controlled by majority shareholder Novo Holdings which holds 28% of its shares and a majority of its voting shares.
Novo is a full member of the European Federation of Pharmaceutical Industries and Associations.
The company was ranked 25th among Fortune's 100 Best Companies to Work For in 2010, and subsequently ranked 72nd in 2014 and 73rd in 2017. In January 2012, Novo was named the most sustainable company in the world by the business magazine Corporate Knights. It is a leader in the FTSE4Good Index, and the only European company in the top ten.
Novo is the largest pharmaceutical company in Denmark. Wikipedia
About Novo Nordisk A/S
CEOMaziar Mike Doustdar
Employees66,7 k
Founded1923
HeadquartersBagsværd, Capital Region of Denmark, Denemarke
SectorPharmaceutical industry
Websitenovonordisk.com